ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0330

Prevalence of Radiographic and Symptomatic Osteoarthritis, and Ultrasound Features at the Knee: The Johnston County Health Study

Maya Patel1, Carolina Alvarez2, Todd Schwartz3, Tessa Walker1, Serena Savage-Guin1, Jordan Renner1, Jonathan Samuels4, Janice Lin5, Minna Kohler6, Catherine Bakewell7, Yvonne Golightly8 and Amanda Nelson1, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Miami, FL, 3University of North Carolina-Chapel Hill, Chapel Hill, NC, 4NYU Langone, Rye Brook, NY, 5Stanford University, Palo Alto, CA, 6Massachusetts General Hospital, Harvard Medical School, Boston, MA, 7Intermountain Healthcare, Salt Lake City, UT, 8University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2025

Keywords: Cohort Study, obesity, Osteoarthritis, radiography, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0306–0336) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: To report sex and BMI differences among ultrasound (US) features of knee osteoarthritis (KOA), patient-reported symptoms (Ksx), radiographic KOA (rKOA), and symptomatic KOA (sxKOA), in a general population.

Methods: Johnston County Health Study participants (JoCoHS, 2019-24, n=902) provided data on demographics, comorbidities, clinical features and symptoms, along with imaging using standardized acquisition and scoring. Prevalence (weighted to the 2020 census population for Johnston County, North Carolina) estimates and 95% confidence intervals (CI) for Ksx, rKOA, sxKOA, severe rKOA, and US features were calculated overall and for sex and BMI subgroups, at the person-level under a stratified sampling design. No formal testing is performed for differences among subgroups, instead CI indicate precision of estimates and the overlap among subgroups. RKOA was defined as Kellgren-Lawrence grade ≥ 2, severe rKOA as grades 3-4, and sxKOA as both rKOA and Ksx in the same knee. Standardized US features were obtained as previously reported (PMID39989271).

Results: The population was majority female (67%), non-Hispanic white (66%) with an average age of 55 ± 10 years and average BMI of 33 ± 8 kg/m2. Of these, 861 individuals had US imaging (no major demographic differences existed compared to the overall group). The overall weighted prevalence of Ksx, rKOA, sxKOA, and severe rKOA, were 61%, 36%, 27%, and 21%, respectively, and all were higher among females and participants with overweight/obesity (Table 1). Among both sexes, rKOA, sxKOA, and severe rKOA were more prevalent among those with severe obesity compared to those with obesity (Table 1). Among those with severe obesity, the prevalence of Ksx was greater among females than males with non-overlapping confidence intervals (Table 1). Mild (grade 1) US features were seen in one-third to one-half of knees. Grey-scale (GS) effusion and synovitis were more prevalent among males compared with females, particularly when moderate or severe (Table 2). In contrast, US findings of medial and lateral cartilage damage were more prevalent in females than males (Table 2). With increasing levels of obesity, effusion/synovitis were less prevalent while osteophytes and medial cartilage damage were more prevalent (Table 3). Additionally, among knees with rKOA compared to those without, osteophytes, meniscal extrusion, calcium crystals, and moderate to severe cartilage damage were much more prevalent (data not shown).

Conclusion: We identified differences in the prevalence of US features of KOA, Ksx, rKOA, sxKOA, and severe rKOA particularly among females with severe obesity. Prior prevalence studies have not distinguished between obesity and severe obesity, due to the relatively small proportion of the population within the severe obesity category. The data above reveals non-overlapping 95% confidence intervals in outcome prevalence among levels of obesity, which should be investigated further. This differentiation could lead to the development of more effective prevention and treatment strategies, as well as a better understanding of the distinct mechanisms driving knee OA in individuals with severe obesity.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: M. Patel: None; C. Alvarez: None; T. Schwartz: None; T. Walker: None; S. Savage-Guin: None; J. Renner: None; J. Samuels: None; J. Lin: None; M. Kohler: Janssen, 5, 12, medical advisory board, Novartis, 12, medical advisory board, Setpoint Medical, 5, Springer Publications, 9; C. Bakewell: AbbVie/Abbott, 2, 6, Eli Lilly, 2, 6, Janssen, 2, 6, Novartis, 2, Pfizer, 2, 6, UCB, 2, 6; Y. Golightly: None; A. Nelson: Novo Nordisk, 1.

To cite this abstract in AMA style:

Patel M, Alvarez C, Schwartz T, Walker T, Savage-Guin S, Renner J, Samuels J, Lin J, Kohler M, Bakewell C, Golightly Y, Nelson A. Prevalence of Radiographic and Symptomatic Osteoarthritis, and Ultrasound Features at the Knee: The Johnston County Health Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-radiographic-and-symptomatic-osteoarthritis-and-ultrasound-features-at-the-knee-the-johnston-county-health-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-radiographic-and-symptomatic-osteoarthritis-and-ultrasound-features-at-the-knee-the-johnston-county-health-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology